SCHEMBL2815432

SCHEMBL2815432

COC(=O)C1(c2ccc(NC(=O)c3ccc(OC)c(OC)c3)cc2)CCCC1

nearest known ligand 0.76

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 10/20 0.76
KDM4E B2RXH2 4/20 0.76
MEN1 O00255 6/20 0.69
NPC1 O15118 5/20 0.69
RAB9A P51151 5/20 0.69
USP2 O75604 2/20 0.62
HDAC1 Q13547 2/20 0.61
MAPT P10636 5/20 0.59
ALDH1A1 P00352 3/20 0.59
PKM P14618 3/20 0.57
POLB P06746 2/20 0.57
HPGD P15428 2/20 0.55
GAA P10253 1/20 0.54
NQO2 P16083 1/20 0.53
CASP3 P42574 1/20 0.53
SENP7 Q9BQF6 1/20 0.53
TP53 P04637 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
CYP2C9 P11712 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2817570 0.91 KMT2A (0.76) KMT2AKDM4EMEN1NPC1RAB9A
SCHEMBL2814616 0.91 KMT2A (0.76) KMT2AKDM4EMEN1NPC1RAB9A
SCHEMBL2819698 0.88 KMT2A (0.80) KMT2AKDM4EMEN1NPC1RAB9A
SCHEMBL2819794 0.87 KMT2A (0.72) KMT2AKDM4EMEN1NPC1RAB9A
SCHEMBL2819535 0.86 KMT2A (1.00) KMT2AKDM4EMEN1NPC1RAB9A
SCHEMBL2815498 0.82 KMT2A (0.67) KMT2AKDM4EMEN1NPC1RAB9A
SCHEMBL2817652 0.82 KMT2A (0.69) KMT2AKDM4EMEN1NPC1RAB9A
SCHEMBL2814882 0.82 KMT2A (0.64) KMT2AKDM4EMEN1NPC1RAB9A
SCHEMBL30683836 0.82 LMNA (0.73) KMT2AKDM4EMEN1HDAC1ALDH1A1
SCHEMBL2814692 0.81 KMT2A (0.66) KMT2AKDM4EMEN1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100249123-A1 NOVEL BENZAMIDE DERIVATIVES AS MODULATORS OF THE FOLLICLE STIMULATING HORMONE ADDEX PHARMA SA (CH) 2010-09-30 US disclosed
CN-101679215-A New benzamide derivatives as the follicle stimulating hormone conditioning agent ADDEX PHARMA SA 2010-03-24 CN disclosed
EP-2134676-A2 NOVEL BENZAMIDE DERIVATIVES AS MODULATORS OF THE FOLLICLE STIMULATING HORMONE Addex Pharma SA (CH) 2009-12-23 EP disclosed
WO-2008117175-A2 NOVEL BENZAMIDE DERIVATIVES AS MODULATORS OF THE FOLLICLE STIMULATING HORMONE ADDEX PHARMA SA (CH) 2008-10-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100249123-A1 NOVEL BENZAMIDE DERIVATIVES AS MODULATORS OF THE FOLLICLE STIMULATING HORMONE FSHR, GNRHR, SHBG KMT2A 1767/4885KDM4E 1395/4885MEN1 150/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.